T1	Participants 13 81	recurrent or persistent nasopharyngeal carcinomas after radiotherapy
T2	Participants 491 531	residual nasopharyngeal carcinomas (NPC)
T3	Participants 669 778	Thirty six NPC patients underwent head and neck CT, Tc-MIBI SPECT, and FDG-PET four months after radiotherapy
T4	Participants 922 934	36 patients.
T5	Participants 935 972	No patients had multiple foci of NPC.
